Global radiation therapy market

2,189 views

Published on

As the technological environment is swiftly undergoing evolution, companies operating in the healthcare/science/pharmaceutical/therapeutic industry are now scaling new heights. Also, the respective sector’s growth is boosted by the rising number of health related issues emanating from the changing lifestyle and incessantly evolving surroundings. To address the rising demand for better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved therapies especially in the field of cancer treatment wherein the radiation therapy is gaining quick acceptance.

Radiation therapy (RT) deploys ionized radiation and limits the proliferation of malignant cells by impairing their DNA. Radiation therapy involves the application of various types of radiations including photons, electron beams, proton beams and neutron beams. Also, the treatment regimes are classified as external radiation therapy, internal radiation therapy or brachytherapy and systemic radioisotope therapy.
Also, industry developments like development of LINACs, rapid Arc therapy and proton therapy; growth drivers including rising cancer cases, increasing use of alcohol and tobacco, expanding obese population and ageing population, rising healthcare expenditure and increasing GNI; and challenges like fatal cancer types, risks associated with treatment procedure and side effects, increasing treatment costs and price pressure among others are discussed in detail. Furthermore, the competitive scenario of the global radiation therapy market, along with the profiles of top 4 industry players viz. Varian, Elekta, Siemens, and Accuray are being included in the report. This report covers global radiation therapy market, regional markets like North America, EMEA, APAC and Latin America.

0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
2,189
On SlideShare
0
From Embeds
0
Number of Embeds
9
Actions
Shares
0
Downloads
0
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Global radiation therapy market

  1. 1. View Report Details Global Radiation Therapy Market--------------------------------------------------- 2012
  2. 2. View Report DetailsExecutive SummaryAs the technological environment is swiftly undergoing evolution, companies operating in thehealthcare/science/pharmaceutical/therapeutic industry are now scaling new heights. Also, the respective sector’s growth is boosted bythe rising number of health related issues emanating from the changing lifestyle and incessantly evolving surroundings.To address the rising demand for better healthcare options and the unmet needs within some of the underlying segments, relatedcompanies are coming up with novel and improved therapies especially in the field of cancer treatment wherein radiation therapy isgaining quick acceptance.Radiation therapy (RT) deploys ionized radiation and limits the proliferation of malignant cells by impairing their DNA. It involvesapplication of various types of radiations including photons, electron beams, proton beams, and neutron beams. Also, the treatmentregimes are classified as external radiation therapy, internal radiation therapy or brachytherapy and systemic radioisotope therapy.This report elicits the global radiation therapy market with focus on key regional markets like North America, EMEA, Asia Pacific andLatin America. Also, industry developments like the development of LINACs, rapid Arc therapy and proton therapy; growth driversincluding rising cancer cases, increasing use of alcohol and tobacco, expanding obese population and ageing population, risinghealthcare expenditure and increasing GNI; and challenges like fatal cancer types, risks associated with treatment procedure and sideeffects, increasing treatment costs and price pressure among others are discussed in detail. Furthermore, the competitive scenario ofthe global radiation therapy market, along with the profiles of top 4 industry players viz. Varian, Elekta, Siemens, and Accuray are beingincluded in the report.By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth ofthe industry. We employed various significant variables that have an impact on this industry and created regression models with SPSSBase to determine the future direction of the industry. Before deploying the regression model, the relationship between severalindependent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, andtests.
  3. 3. Radiation therapy (RT), also termed as radiation oncology/radiotherapy, deploys high energy radiation to damage cancer cells, restricting their multiplication Global Radiation Therapy Market (2001-2011) The worldwide radiation therapy market registered a 2011 compound annual growth rate of …..% from US$.....billion in 2010 2001 to US$..... billion in 2011. The market declined by …..% 2009 from US$..... billion in 2008 to US$.....billion in 2009, on 2008 account of the global economic slowdown which affected 2007 almost all the industries worldwide. 2006 With the ameliorating economic conditions, the number of 2005 radiation therapy procedures performed also increased and 2004 the market for radiation therapy reached US$....billion in 2003 2011. 2002 2001 In terms of region, North America represents the major developed market for radiation therapy world over, and it is mainly due to advancements in technology adoption. In US$ Billion 2011, North America constituted a major share of …..% of the global radiation therapy market, followed by the EMEA region, accounting for ……% share of the same. Global Radiation Therapy Market by Region (2011)  Industry Developments: -Proton Therapy -RapidArc Therapy -LINACs Market Growth Drivers -Prevalence of Cancer -Use of alcohol and tobacco -Rising obese population and ageing population -Increasing healthcare expenditure -Demand for better healthcare options North America EMEA APAC Latin America
  4. 4. Factors such as increasing life expectancy rates, technology adoption and changing lifestyles are expected to increase the number of cancer patients in the developing countries North America’s Radiation Therapy Market (2001-2011) North America is the leading market for radiation therapy all across the globe. At present, it is characterized as a replacement market.2011 The region accounted for around …..% share in the global radiation therapy market as of 2011. The North American RT market had2010 grown from US$....billion in 2001 to US$.....billion in 2011, chiefly as2009 a result of increasing cancer incidence rate as well as the favorable2008 government reimbursements policies associated with its treatment.2007  The radiation therapy market in the EMEA region was valued at2006 US$...... billion in 2001 which increased to US$...... billion in 2011.2005 The Asia Pacific region is one of the rapidly evolving markets for2004 radiation therapy, as the low penetration rate offers huge potential for2003 future growth. The Asia Pacific market for radiation therapy has grown with a CAGR of …….% over a ten year period from 2001 to2002 2011 from US$.......billion to US$..... billion.2001 US$ Billion APAC’s Radiation Therapy Market (2001-2011) EMEA’s Radiation Therapy Market (2001-2011) ) US$ Billion US$ Billion 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
  5. 5. The market is highly consolidated and fiercely competitive, with the top two players accounting for roughly 78% of the total market… Latin America’s Radiation Therapy Market (2001-2011) Global Radiation Therapy Market Forecast (2010-2014E)201120102009 US$ Billion20082007200620052004200320022001 US$ Billion 2010 2011 2012E 2013E 2014E  Latin America accounted for the lowest share, …..%, of the global radiation therapy market as of 2011. But, it is acknowledged as one of the key emerging markets for radiation therapy with an impeccable CAGR of ……% over a time span of ten years (2001 to 2011), offering huge growth potential in the years to come. The Latin American radiation therapy market increased from US$......billion in 2001 to US$............billion in 2011. On the competition front, Varian is the leading company in the market for radiation therapy world over, with approximately ……% of the market share for the year 2011, followed by Elekta with ……%. Siemens is the third largest company in the RT market with ………% share. Taking into account the numerous factors and growth drivers affecting the growth of global radiation therapy market, for the year 2012, the market opportunity of the same is anticipated to be US$............ billion, an estimated growth of ………% as compared to US$........... billion in 2011. The global radiation therapy market is likely to grow from US$......... billion in 2011 to US$........... billion in 2014, at a CAGR of ……….%. Key Issues faced by the respective industry include: Patient safety concerns, fatality of tumors, skyrocketing treatment costs and stringent regulatory measures Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa
  6. 6. Table of Contents List of Graphs & Tables 1. Radiation Therapy (RT) List of Charts 1.1 Overview Global Radiation Therapy Market (2001-2011) Global Radiation Therapy Market by Region (2011) 1.2 Types of Radiation Therapy Radiation Therapy Market CAGR by Region (2001-2011) 1.2.1 External-Beam Radiation Therapy Radiotherapy Equipment Order by Region (2009-2013E) 1.2.2 Internal Radiation Therapy North America’s Radiation Therapy Market (2001-2011) 1.2.3 Systemic Radioisotope therapy EMEA’s Radiation Therapy Market (2001-2011) APAC’s Radiation Therapy Market (2001-2011) 1.3 RT Action Mechanism Latin America’s Radiation Therapy Market (2001-2011) 1.4 RT Effect on Different Cancer Types Number of Proton Therapy Centers Worldwide (2000-2011) Number of Cancer Cases Worldwide (2007-2011) 2. Radiation Therapy - Market Size Global Lung Cancer Incidences (2010 & 2030E) Global Breast Cancer Incidences (2010 & 2030E) 2.1 Global Radiation Therapy Market Global Prostate Cancer Incidences (2010 & 2030E) Growth in Worldwide Obese Population (2004-2012F) Market Value Global Ageing Population (2005-2013F) Growth Rate Global Healthcare Spending (2005-2015E) Regional Breakdown World Gross National Income (2005-2010) Order Growth Stages of a Radiotherapy Treatment Global Radiation Therapy Market Share by Company (2011) 2.2 Radiation Therapy Market by Region Japan’s RT Market Share by Company (FY11/12) China’s RT Market Share by Company (2011) 2.2.1 North America India’s RT Market Share by Company (2011) 2.2.2 EMEA Varian Medical Systems’ Revenue Share by Business Segments (2011) 2.2.3 APAC Varian Medical Systems’ Revenues and Net Earnings (2008-2011) 2.2.4 Latin America Elekta’s Revenue Share by Business Segments (2011) Elekta’s Revenues and Profit (FY 08/09-FY 11/12) 3. Radiation Therapy - Market Dynamics Accuracy’s Revenues and Net Income (2009-2012) Siemens AG’s Revenue Share by Business Segments (2011) 3.1 Industry Developments Siemens AG’s Revenues and Net Income (2008-2011) Global Radiation Therapy Market Forecast (2010-2014E) 3.1.1 Development of Proton Therapy 3.1.2 Innovative RapidArc Therapy 3.1.3 Development of Linear Accelerators (LINAC)
  7. 7. 3.2 Growth Drivers List of Tables3.2.1 Increasing Prevalence of Cancer3.2.2 Increasing Use of Tobacco and Alcohol Estimated Cancer Cases in the US (2012)3.2.3 Expanding Obese Population Estimated Cancer Deaths in the US (2012)3.2.4 Rising Demand for Better Healthcare Options Patients Worldwide Waiting for Better Treatment Options (2011)3.2.5 Growing Ageing Population (+60 Years) FDA Regulation of Medical Devices3.2.6 Rising Healthcare Expenditure North America’s RT Market Share by Company (2011)3.2.7 Increasing Global GNI (Gross National Income) EMEA’s RT Market Share by Company (2011) APAC’s RT Market Share by Company (2011)3.3 Challenges Dependent & Independent Variables (2007–2011) Correlation Matrix3.3.1 Patient Safety during the Treatment Process Model Summary – Coefficient of Determination3.3.2 Highly Fatal Cancers Regression Coefficients Output3.3.3 Rising Costs of Treatment3.3.4 Stringent Regulatory Measures3.3.5 Adverse Effects of the Treatment3.3.6 Escalating Price Pressure4. Competitive Landscape4.1 Competitive Scenario by Geographic Region4.1.1 North America4.1.2 EMEA4.1.3 APAC4.1.4 Japan4.1.5 China4.1.6 India5. Company Profiles5.1 Varian Medical Systems Inc.5.1.1 Business Overview5.1.2 Financial Overview5.1.3 Business Strategies-Focus on Research & Development-Expanding Product Portfolio
  8. 8. 5.2 Elekta5.2.1 Business Overview5.2.2 Financial Overview5.2.3 Business Strategies-Partnerships with Research Institutions-Focus on Product Development5.3 Accuray Inc.5.3.1 Business Overview5.3.2 Financial Overview5.3.3 Business Strategies-Intense Research & Development Activities-Strategic Collaborations5.4 Siemens AG5.4.1 Business Overview5.4.2 Financial Overview5.4.3 Business Strategies-Accelerating R&D Activities-Focus on Healthcare Segment6. Market Outlook6.1 Market Forecast6.2 Forecast Methodology6.2.1 Dependent and Independent Variables6.2.2 Correlation Analysis6.2.3 Regression Analysis
  9. 9. Contact Us: View Report DetailsThese are abridged and sanitized sample pages from the comprehensive report on the “Global Radiation Therapy Market”. Toknow more about this report or for any customized research requirement, please contact the following: Koncept Analytics CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 Vikas Gupta T. +91-120-4130959 BD Manager C: +91-9811715635 vikas@konceptanalytics.com www.konceptanalytics.com

×